Showing 35,599 results

Filters
Injectable & long-acting HIV treatment

AIDS 2026: Once-weekly tablet for HIV treatment Video

July 2026
Finance & funding

PEPFAR cuts close key population services and accelerate decline in children's HIV treatment

News
31 July 2026
PEP

Promise of monthly oral pill sparks renewed interest in post-exposure prophylaxis (PEP)

News
30 July 2026
Injectable & long-acting HIV treatment

Once-weekly islatravir / lenacapavir combination pill maintains HIV viral suppression

News
30 July 2026
Injectable & long-acting HIV treatment

Islatravir plus ulonivirine shows promise for weekly oral HIV treatment

News
30 July 2026
Starting treatment

Dolutegravir knocks down HIV faster than bictegravir

News
30 July 2026
Injectable & long-acting HIV treatment

Long-acting injectable treatment superior to daily pills for adolescents in African trial

News
30 July 2026
Economic & social inequality

Water insecurity nearly quadruples odds of poor HIV outcomes, while hunger and partner violence compound risk in East Africa

News
29 July 2026
Injectable & long-acting PrEP

Monthly PrEP pill could be made for US$3 a year, but Latin America is shut out of generic licensing

News
29 July 2026
Injectable & long-acting PrEP

Nearly 200,000 lenacapavir shots given across Africa, but supply issues pose challenges

News
29 July 2026
Access to healthcare

Countries in Latin America and the Caribbean helped build the future of HIV prevention. But will they be able to benefit from it?

Editor's pick
Unitaid
27 July 2026
Conference announcements & declarations

An Inside Look at the AIDS 2026 Clinical Agenda

Editor's pick
TheBodyPro
27 July 2026
Pharmaceutical industry

Oil price shocks could raise the cost of HIV medicines by up to 44%, Unitaid analysis finds

Editor's pick
Unitaid
27 July 2026
HIV & criminal law

Pennsylvania ends enhanced criminal penalties for people living with HIV

Editor's pick
LGBTQ Nation
27 July 2026
Access to healthcare

Activists React to Merck’s Voluntary License for Generic Production of Investigational Long-Acting Oral PrEP Product, Alimatravir

Editor's pick
Health GAP (Global Access Project)
27 July 2026
Injectable & long-acting PrEP

This drug could help end the HIV epidemic. Its rollout has hit speed bumps

Editor's pick
Science
27 July 2026
Global health initiatives

Amid Row Over Exclusion, US Concedes that HIV Approach Needs to Include ‘All People at Risk’

Editor's pick
Health Policy Watch
27 July 2026
Bad science & bogus treatments

Zimbabwe farmers feed ARVs to chickens in bid to boost growth

Editor's pick
Daily Maverick
27 July 2026
Government, leadership & policy

The US State Department Redraws the Map of Africa at the AIDS2026 Conference

Editor's pick
To End a Plague ... Again
27 July 2026
Government, leadership & policy

AIDS 2026: Activists challenge US Government’s claims to manage PEPFAR

Editor's pick
i-Base
27 July 2026
Finance & funding

Funding for the global HIV response plunged in 2025, with devastating consequences

Editor's pick
International AIDS Society (IAS)
27 July 2026
Access to healthcare

With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access

Editor's pick
The New York Times (requires free registration)
26 July 2026
Access to healthcare

Russia destroys Ukraine HIV warehouse

Editor's pick
The Telegraph
23 July 2026
PrEP policies & guidelines

South Africa: Motsoaledi defends limited rollout of lenacapavir amid challenges

Editor's pick
IOL
16 July 2026